Gavras H, Gavras I, Brunner H R
Compr Ther. 1980 May;6(5):14-8.
Inhibition of the angiotensin-converting enzyme emerges as a new promising approach to the treatment of hypertension. The intravenously administered teprotide appears to be suitable as a diagnostic test and for initial treatment of certain hypertensive emergencies. The oral inhibitor captopril is effective for chronic maintenance of blood pressure control in various types of hypertension but has been associated with a number of adverse reactions.
抑制血管紧张素转换酶成为治疗高血压的一种新的有前景的方法。静脉注射替普罗肽似乎适合作为诊断试验以及用于某些高血压急症的初始治疗。口服抑制剂卡托普利对各类高血压的血压控制慢性维持有效,但已出现一些不良反应。